Dialogue Around Respiratory Illness Treatment

Status unconfirmed · Not applicable

Conditions studied: Respiratory Disease, Acute Respiratory Infection, Respiratory Infection, Upper Respiratory Infection

In brief

Unwarranted use of antibiotics for pediatric acute respiratory tract infections (ARTIs) and use of second-line, broad spectrum antibiotics for bacterial ARTIs has contributed to the rapid development of resistance in many strains of bacteria. Provider-parent communication during pediatric visits for ARTIs strongly influence antibiotic prescribing rates. The overall goal of this study is to develop and test a distance learning quality improvement (QI) program called Dialogue Around Respiratory Illness Treatment - DART. The DART program aims to improve provider communication practices and treatment decisions during pediatric ARTI visits, with the ultimate goal being to decrease rates of antibiotic prescribing for these illnesses in children.

Key facts

Study ID
NCT02943551
Run by
Seattle Children's Hospital
People needed
2728
Starts
2016-07-18
Expected to finish
2020-06-30
Last updated by the study team
2019-07-16

Who can join

Age: 1 and older, up to 10. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.